Investors

Shield Therapeutics is well positioned to become a fast growing, independent, international specialty pharmaceutical company.

Advisor Contacts

Nominated Advisor and Joint Broker

Liberum, Ropemaker Place
25 Ropemaker Street, London
EC2Y 9LY

Tel: +44 (0)20 3100 2000

Joint Broker

Peel Hunt LLP
120 London Wall
London
EC2Y 5ET

Tel: +44 (0)20 7418 8900

Auditors

KPMG LLP, Quayside House, 110 Quayside
Newcastle Upon Tyne
NE1 3DX

Tel: +44 (0)19 1401 3700

Legal Advisors

Stephenson Harwood LLP
1 Finsbury Circus, London
EC2M 7SH

Tel: +44 (0)20 7329 4422

Tax Advisors

Ernst & Young LLP
Citygate
St James’ Boulevard Newcastle upon Tyne
NE1 4JD

Tel: +44 (0)19 1247 2500

Financial PR

Consilium Strategic Communications
41 Lothbury, London
EC2R 7HG

Tel: +44 (0)20 3709 5700

Registrar

Link Asset Services Limited
The Registry
34 Beckenham Road
Beckenham
Kent
BR3 4TU

Tel: +44 (0)871 664 0300

Analysts Coverage

Roger Franklin, Liberum Capital Limited
Amy Walker, Peel Hunt
Nick Keher, RBC Capital

Shield Therapeutics plc

Shield Therapeutics plc
Northern Design Centre
Gateshead Quays, Gateshead
NE8 3DF

Tel: +44 (0)191 511 8500

Email: investorrelations@shieldtx.com